| Concomitant |
| Drug Use For Unknown Indication |
24.3% |
| Product Used For Unknown Indication |
14.1% |
| Depression |
10.4% |
| Schizophrenia |
4.8% |
| Schizophrenia, Paranoid Type |
4.8% |
| Pain |
4.4% |
| Insomnia |
4.2% |
| Analgesia |
3.6% |
| Insulin-requiring Type Ii Diabetes Mellitus |
3.2% |
| Hypertension |
3.0% |
| Laxative Supportive Care |
3.0% |
| Analgesic Therapy |
2.8% |
| Anxiety |
2.6% |
| Constipation |
2.6% |
| Prophylaxis Of Nausea And Vomiting |
2.4% |
| Breast Cancer |
2.2% |
| Osteoporosis |
2.0% |
| Asthma |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Malaise |
1.8% |
|
| Withdrawal Syndrome |
14.7% |
| Vomiting |
9.5% |
| Pain |
8.4% |
| Vertigo |
7.4% |
| Pain In Extremity |
6.3% |
| Pulmonary Embolism |
5.3% |
| Respiratory Tract Infection |
5.3% |
| Suicidal Ideation |
4.2% |
| Tearfulness |
4.2% |
| Vision Blurred |
4.2% |
| Wheezing |
4.2% |
| Dyspnoea |
3.2% |
| International Normalised Ratio Increased |
3.2% |
| Loss Of Consciousness |
3.2% |
| Lower Respiratory Tract Infection |
3.2% |
| Malaise |
3.2% |
| Sinus Tachycardia |
3.2% |
| Weight Decreased |
3.2% |
| Antipsychotic Drug Level Increased |
2.1% |
| Atrial Flutter |
2.1% |
|
